Molecular surveillance of chloroquine-resistant Plasmodium falciparum in sub-Saharan African countries after withdrawal of chloroquine for treatment of uncomplicated malaria: A systematic review

被引:10
|
作者
Njiro, Belinda J. [1 ]
Mutagonda, Ritah F. [1 ]
Chamani, Amisa T. [1 ]
Mwakyandile, Tosi [1 ]
Sabas, Deodatus [1 ]
Bwire, George M. [1 ]
机构
[1] Muhimbili Univ Hlth & Allied Sci, POB 65001, Dar Es Salaam, Tanzania
关键词
Chloroquine; Sub-Saharan Countries; Plasmodium falciparum; Pfcrt; Pfmdr1; ANTIMALARIAL-DRUG RESISTANCE; TRANSPORTER GENE; MARKERS; PFCRT; SUSCEPTIBILITY; LUMEFANTRINE; PREVALENCE; MUTATIONS; GENOTYPES; DISTRICT;
D O I
10.1016/j.jiph.2022.03.015
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: A wide spread of chloroquine resistance prompted its discontinued use for treatment of uncomplicated malaria in several African countries. However, disappearances of chloroquine-resistant parasites have been reported in areas with restricted use of chloroquine. This review reports the current prevalence of chloroquine-resistant Plasmodium falciparum using Pfcrt K76T and Pfmdr1 N86Y genotypes. Methods: A PROSPERO registered systematic review searched evidence from PubMed/MEDLINE, Science Direct and Google Scholar. The search included studies on chloroquine-resistant/ susceptible P. falciparum in humans between January 1st, 2000 and May 15th, 2020. The search was conducted on 15th of May, 2020. Results: Out of 519 searched records, 15 studies qualified for final analysis with 8040 samples genotyped for Pfcrt K76T. Of 8040, 43.6% (837/1572; 95%CI: -0.9 to 88.1%) carried resistant genotypes versus 23.0% (1477/ 6468; 95%CI: 15.7-30.2%) while for 4698 samples analyzed for Pfmdr1 N86Y, 52.4% (592/1090; 95%CI: 42.3-62.5%) had resistant genotypes versus 25.9% (1314/3608; 95%CI: 5.8-46.0%), before and after chloroquine withdrawal, respectively. The median time since chloroquine withdrawal to data collection was 7.0 (interquartile range: 4.5-13.5) years. Low prevalence of resistant genotypes (Pfcrt K76T) was reported in Zambia (0%) in 2013, Malawi (0.1%) in 2009, Tanzania (0.2%) in 2018 and Madagascar (0.3%) in 2007 with significant variations in the included studies. Conclusions: Chloroquine-resistant P. falciparum continues to disappear in countries with withdrawal of chloroquine. Areas with significant susceptible parasites, reintroduction of chloroquine can be considered, preferably in combination with other safe and affordable antimalarials. (c) 2022 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. CC_BY_NC_ND_4.0
引用
收藏
页码:550 / 557
页数:8
相关论文
共 50 条
  • [31] Molecular epidemiology of malaria in Cameroon.: XIV.: Plasmodium falciparum chloroquine resistance transporter (PFCRT) gene sequences of isolates before and after chloroquine treatment
    Basco, LK
    Ndounga, M
    Ngane, VF
    Soula, G
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2002, 67 (04): : 392 - 395
  • [32] Prevalence of chloroquine resistance alleles among Plasmodium falciparum parasites in countries affected by malaria disease since change of treatment policy: a systematic review protocol
    Ocan, Moses
    Akena, Dickens
    Nsobya, Sam
    Kamya, Moses R.
    Senono, Richard
    Kinengyere, Alison Annet
    Obuku, Ekwaro A.
    SYSTEMATIC REVIEWS, 2018, 7
  • [33] Prevalence of chloroquine resistance alleles among Plasmodium falciparum parasites in countries affected by malaria disease since change of treatment policy: a systematic review protocol
    Moses Ocan
    Dickens Akena
    Sam Nsobya
    Moses R. Kamya
    Richard Senono
    Alison Annet Kinengyere
    Ekwaro A. Obuku
    Systematic Reviews, 7
  • [34] Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults
    Sagara, Issaka
    Oduro, Abraham R.
    Mulenga, Modest
    Dieng, Yemou
    Ogutu, Bernhards
    Tiono, Alfred B.
    Mugyenyi, Peter
    Sie, Ali
    Wasunna, Monique
    Kain, Kevin C.
    Djimde, Abdoulaye A.
    Sarkar, Shirsendu
    Chandra, Richa
    Robbins, Jeffery
    Dunne, Michael W.
    MALARIA JOURNAL, 2014, 13
  • [35] Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults
    Issaka Sagara
    Abraham R Oduro
    Modest Mulenga
    Yemou Dieng
    Bernhards Ogutu
    Alfred B Tiono
    Peter Mugyenyi
    Ali Sie
    Monique Wasunna
    Kevin C Kain
    Abdoulaye A Djimdé
    Shirsendu Sarkar
    Richa Chandra
    Jeffery Robbins
    Michael W Dunne
    Malaria Journal, 13
  • [36] Polymorphisms in Pfcrt and Pfmdr-1 genes after five years withdrawal of chloroquine for the treatment of Plasmodium falciparum malaria in West Bengal, India
    Chatterjee, Moytrey
    Ganguly, Swagata
    Saha, Pabitra
    Guha, Subhasish Kamal
    Basu, Nandita
    Bera, Dilip K.
    Maji, Ardhendu Kumar
    INFECTION GENETICS AND EVOLUTION, 2016, 44 : 281 - 285
  • [37] Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis
    Marwa, Karol
    Kapesa, Anthony
    Baraka, Vito
    Konje, Evelyne
    Kidenya, Benson
    Mukonzo, Jackson
    Kamugisha, Erasmus
    Swedberg, Gote
    PLOS ONE, 2022, 17 (03):
  • [38] Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy
    Aurore Ogouyèmi-Hounto
    Nicaise Tuikue Ndam
    Dorothée Kinde Gazard
    Sitou d’Almeida
    Lucette Koussihoude
    Elvire Ollo
    Carmine Azagnandji
    Mourchidath Bello
    Jean-Phillipe Chippaux
    Achille Massougbodji
    Malaria Journal, 12
  • [39] Prevalence of the molecular marker of Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in Benin seven years after the change of malaria treatment policy
    Ogouyemi-Hounto, Aurore
    Ndam, Nicaise Tuikue
    Gazard, Dorothee Kinde
    d'Almeida, Sitou
    Koussihoude, Lucette
    Ollo, Elvire
    Azagnandji, Carmine
    Bello, Mourchidath
    Chippaux, Jean-Phillipe
    Massougbodji, Achille
    MALARIA JOURNAL, 2013, 12
  • [40] Multicentric assessment of the efficacy and tolerability of dihydroartemisinin-piperaquine compared to artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa
    Yavo, William
    Faye, Babacar
    Kuete, Thomas
    Djohan, Vincent
    Oga, Serge A.
    Kassi, Richard R.
    Diatta, Mariama
    Ama, Moor V.
    Tine, Roger
    Ndiaye, Jean-Louis
    Evi, Jean-Bedel
    Same-Ekobo, Albert
    Faye, Oumar
    Kone, Moussa
    MALARIA JOURNAL, 2011, 10